AIM’s Latest Newsletter: The Research Edition, July 2023

Published:  
08/01/2023
Categories:  
Blog - Melanoma360
 | 
Melanoma Research
Image

This month’s newsletter focuses on the latest news and scientific breakthroughs in melanoma research.

This edition features:

  • Letter from AIM’s President, Sam Guild
  • Notes From the Lab: Novel Targets for Immune Checkpoint Inhibitors
    By Paul Bunk, Ph.D. candidate, Cold Springs Harbor Laboratory
  • In Plain English: Neoadjuvant Therapy for Melanoma, and How We Got Here
    By Kim Margolin, M.D., FACP, FASCO
  • Clinical Trials Catch Up: An Interview with Joshua M.V. Mammen, M.D., Ph.D., F.A.C.S.
    By Alicia Rowell, Vice President, AIM at Melanoma

Recent Posts

Featured image for “One Day at a Time: Caregiving Through Ocular Melanoma”
Dec. 09, 2025

One Day at a Time: Caregiving Through Ocular Melanoma

Featured image for “A Life Rewritten: Finding Strength in the Face of Melanoma”
Nov. 24, 2025

A Life Rewritten: Finding Strength in the Face of Melanoma

Featured image for “Living Through TIL Therapy: A Personal Story”
Nov. 20, 2025

Living Through TIL Therapy: A Personal Story

Featured image for “You’re Not Out of Options: What to Do When First-Line Melanoma Treatment Fails”
Nov. 07, 2025

You’re Not Out of Options: What to Do When First-Line Melanoma Treatment Fails

Featured image for “Honoring Veterans and Raising Awareness About Skin Cancer”
Nov. 06, 2025

Honoring Veterans and Raising Awareness About Skin Cancer

Filter by Tag